Associated Papers
Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.
Claahsen-van der Grinten HL et al.
Endocrine Reviews, 2022
The Presence of Clitoromegaly in the Nonclassical Form of 21-Hydroxylase Deficiency Could Be Partially Modulated by the CAG Polymorphic Tract of the Androgen Receptor Gene.
Moura-Massari VO et al.
Plos One, 2016
46,XY disorder of sexual development resulting from a novel monoallelic mutation (p.Ser31Phe) in the steroid 5α-reductase type-2 (SRD5A2) gene.
Chávez B et al.
Molecular Genetics & Genomic Medicine, 2014
Overview of genetic defects in endocrinopathies in the island of Cyprus; evidence of a founder effect.
Shammas C et al.
Genetic Testing and Molecular Biomarkers, 2012
Steroid 5-{alpha}-reductase Type 2 (SRD5a2) gene polymorphisms and risk of prostate cancer: a HuGE review.
Li J et al.
American Journal of Epidemiology, 2010
Pharmacogenetic analysis of human steroid 5 alpha reductase type II: comparison of finasteride and dutasteride.
Makridakis N et al.
Journal of Molecular Endocrinology, 2005
Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II.
Makridakis NM et al.
Pharmacogenetics, 2000
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
White PC et al.
Endocrine Reviews, 2000
Select a paper to view details